24 Nov 2006

Pharmaceutical company Meda held the bank meeting for the amendment to its Eu575m five year loan in Stockholm this week. The amendment is to several financial covenants on the loan and will allow the borrower to take on more debt for its purchase of the European drug wing ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.